Up to $130,000, including 10% indirect costs, for clinical trials; and not above $110,000, including 10% indirect costs, for lab-based studies. - June 2, 2026 (pre-application)
Crohn's and Colitis Foundation of America, Inc. (CCFA)This supports pioneering clinical and translational research focused on improving diagnosis, identifying subsets, and developing treatments for inflammatory bowel diseases (IBD).
